Received Nov 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
dose was reconstituted with a Shingrix antigen plus an Arexvy diluent / which patient got the incorrectly reconstituted product; dose was reconstituted with a Shingrix antigen plus an Arexvy diluent / which patient got the incorrectly reconstituted product; This non-serious case was reported by a pharmacist via sales rep and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On 18-OCT-2025, the patient received Shingrix (unknown deltoid). On 18-OCT-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: dose was reconstituted with a Shingrix antigen plus an Arexvy diluent / which patient got the incorrectly reconstituted product) and inappropriate dose of vaccine administered (Verbatim: dose was reconstituted with a Shingrix antigen plus an Arexvy diluent / which patient got the incorrectly reconstituted product). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 22-OCT-2025 Two patients came into the pharmacy to get Shingrix. Two vials of Shingrix antigen were pulled. One dose was reconstituted correctly but one dose was reconstituted with a Shingrix antigen plus an Arexvy diluent due to packages and vials looking too similar. Pharmacist shared that they were unsure which patient got the correct Shingrix mixture, and which patient got the incorrectly reconstituted product. The batch number was not provided, and we are unable to contact the reporter.